Assessment of intracellular TAP-1 and TAP-2 in conjunction with surface MHC class I in plasma cells from patients with multiple myeloma

British Journal of Haematology

Volumn 98, Issue 2, 1997, Pages 426-432

  Crucian, Brian E ^a,b   Moscinski, Lynn C ^a   Androlewicz, Matthew ^a   Ballester, Oscar F ^a   Widen, Raymond H ^c   Yu, Hua ^a,b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c TAMPA GENERAL HOSPITAL   (United States)

Author keywords

Intracellular flow cytometry; Multiple myeloma; Plasma cells; TAP and MHC class I; Target of immunotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IDARUBICIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MELPHALAN; PREDNISONE; VINCRISTINE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0030861842     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.2173032.x     Document Type: Article

References (38)

1. Androlewicz, M.J., Anderson, K.S. & Cresswell, P. (1993) Evidence that transporters associated with antigen processing translocate a major histocompatability complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. Proceedings of the National Academy of Sciences of the United States of America, 90, 9130-9134.
2. Androlewicz, M.J. & Cresswell, P. (1994) Human transporters associated with antigen processing possess a promiscuous peptide-binding site. Immunity, 1, 7-14.
3. Androlewicz, M.J. & Cresswell, P. (1996) How selective is the transporter associated with antigen processing? Immunity, 5, 1-5.
4. Barnstable, C.J., Bodmer, W.F., Brown, G., Galfre, G., Milsein, C., Williams, A.F. & Ziegler, A. (1978) Production of mononuclear antibodies to group A erytherocytes. HLA and other human cell surface antigens: new tools for genetic analysis. Cell, 14, 9-20.
5. Benyunes, M.C., Higuchi, C., York, A., Lindgren, C., Thompson, J.A., Buckner, C.D. & Fefer, A. (1995) Immunotherapy with interleukin 2 with or without lymphokine-activated killer cells after autologous bone marrow transplantation for malignant lymphoma: a feasibility trial. Bone Marrow Transplantation, 16, 283-288.
6. Bergenbrant, S., Yi, Q., Osterborg, A., Bjorkholm, M., Osby, E., Mellstedt, H., Lefvert, A.K. & Holm, G. (1996) Modulation of an anti-idiotypic immune response by immunization with the autologous M-component protein in multiple myeloma patients. British Journal of Haematology, 92, 840-846.
7. Ciernik, F., Berzofsky, J.A. & Carbone, D.P. (1996) Induction of cytotoxic T lymphocytes and antitumour immunity with DNA vaccines expressing single T cell epitopes. Journal of Immunology, 156, 2369-2375.
8. Cromme, F.V., Airey, J., Heemels, M.T., Ploegh, H.L., Keating, P.J., Stern, P.L., Meijer, C.J.L. & Walboomers, J.M.M. (1994a) Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. Journal of Experimental Medicine, 179, 355-340.
9. Cromme, F.V., van Bommel, P.F.J., Walboomers, J.M.M., Gallee, M.P.W., Stern, P.L., Kenemans, P., Helmerhorst, Th.J.M., Stukart, M.J. & Meijer, C.J.L.M. (1994b) Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours. British Journal of Cancer, 69, 1176-1181.
10. DeMars, R., Chang, C.C., Shaw, S., Reitnauer, P.J. & Sondel, P.M. (1984) Homozygous deletions that simultaneously eliminate expressions of class I and class II antigens of EBV-transformed B-lymphoblastoid cells. I. Reduced proliferative responses of autologous and allogenic T cells to mutant cells that have decreased expression of class II antigens. Humoral Immunology, 11, 77-97.
11. Dohlsten, M., Lando, P.A., Bjork, P., Abrahmsen, L., Ohlsson, L., Lind, P. & Kalland, T. (1995) Immunotherapy of human colon cancer by antibody-targeted superantigens. Cancer Immunology and Immunotherapy, 41, 162-168.
12. Durie, B.G.M. & Salmon, S.E. (1975) A clinical staging system for multiple myeloma. Cancer, 36, 842-854.
13. Gabathuler, R., Reid, G., Kolaitis, G., Driscoll, J. & Jefferies, W.A. (1994) Comparison of cell lines deficient in antigen presentation reveals a functional role for TAP-1 alone in antigen processing. Journal of Experimental Medicine, 180, 1415-1425.
14. George, A.J.T., Folkard, S.G., Hamblin, T.J. & Stevenson, F.K. (1988) Idiotypic vaccination as a treatment for a B cell lymphoma. Journal of Immunology, 141, 2168-2174.
15. Hokland, M., Basse, P., Justesen, J. & Hokland, P. (1988) IFN-induced modulation of histocompatability antigens on human cells, background, mechanisms and perspectives. Cancer and Metastasis Reviews, 7, 193-207.
16. Hosken, N.A. & Bevan, M.J. (1990) Defective presentation of endogenous antigen by a cell line expressing class I molecules. Science, 248, 367-370.
17. Hsu, F.J., Benike, C., Fagnoni, F., Liles, T.M., Czerwinski, D., Taidi, B., Engleman, E.G. & Levy, R. (1996) Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Medicine, 2, 52-58.
18. + T cells. Cell, 71, 1205-1214.
19. Kaklamanis, L., Leek, R., Koukourakis, M., Gatter, K.C. & Harris, A.L. (1995) Loss of transporter in antigen processing 1 transport protein and major histocompatability complex class I molecules in metastatic versus primary breast cancer. Cancer Research, 55, 5191-5194.
20. Kaklamanis, L., Townsend, A., Doussis-Anagnostopoulou, I.A., Mortensen, N., Harris, A.L. & Gatter, K.C. (1994) Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer. American Journal of Pathology, 145, 505-509.
21. Kawakami, Y., Eliyahu, S., Delgado, C., Robbins, P., Sakaguchi, K., Appella, E., Yannelli, J., Adema, G., Miki, T. & Rosenberg, S. (1994) Identification of a human melanoma antigen recognized by tumour-infiltrating lymphocytes associated with in vivo tumor rejection. Proceedings of the National Academy of Sciences of the United States of America, 91, 6458-6462.
22. Korkolopoulou, P., Kaklamanis, L., Pezzella, F., Harris, A.L. & Gatter, K.C. (1996) Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer. British Journal of Cancer, 73, 148-152.
23. Kyle, R.A. (1992) Diagnostic criteria of multiple myeloma. Hematology/Oncology Clinics of North America, 6, 347-357.
24. Kwak, L.W., Campbell, M.J., Czerwinski, D.K., Hart, S., Miller, R.A. & Levy, R. (1992) Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. New England Journal of Medicine, 327, 1209-1215.
25. Meyer, T.H., van Endert, P.M., Uebel, S., Ehring, B. & Tampe, R. (1994) Functional expression and purification of the ABC transporter complex associated with antigen processing (TAP) in insect cells. FEBS Letters, 351, 443-447.
26. Moscinski, L.C. & Ballester, O.F. (1994) Recent progress in multiple myeloma. Hematological Oncology, 12, 111-123.
27. Neefjes, J.J., Momburg, F. & Hammerling, G.J. (1993) Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science, 261, 769-771.
28. Osterborg, A., Yi, Q., Bergenbrant, S., Holm, G., Lefvert, A.K. & Mellstedt, H. (1995) Idiotype-specitic T cells in multiple myeloma stage I: an evaluation by four different functional tests. British Journal of Haematology, 89, 110-116.
29. + T cells against the wild-type tumour: correlation with antigen presentation capability. Journal of Experimental Medicine, 175, 1423-1431.
30. Rosenberg, S.A., Packard, B.S., Aebersold, P.M., Solomon, D., Topalian, S.L., Toy, S.T., Simon, P., Lotze, M.T., Yang, J.C., Seipp, C.A., Simpson, C., Carter, C., Bock, S., Schwartzentruber, D.J., Wei, J.P. & White, D.E. (1988) Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma: a preliminary report. New England Journal of Medicine, 319, 1676-1680.
31. Routes, J.M. (1992) IFN increases class I MHC antigen expression on adenovirus-infected human cells without inducing resistance to natural killer cell killing. Journal of Immunology, 149, 2372-2377.
32. Salter, R.D., Howell, D.N. & Cresswell, P. (1985) Genes regulating HLA Class I antigen expression in T-B lymphoblast hybrids. Immunogenetics, 21, 235-246.
33. Shulman, L.N. (1995) Plasma cell diseases and related disorders. Blood: Principles and Practice of Hematology (ed. by R. I. Handin, S. E. Lux and T. P. Stossel), pp. 885-913. Lippincott, Philadelphia.
34. Spies, T.M., Bresnahan, M., Bahram, S., Arnold, D., Blank, G., Mellins, E., Pious, D. & DeMars, R. (1990) A gene in the human major histocompatability complex class II region controlling the class I antigen presentation pathway. Nature, 348, 741-747.
35. Stevenson, F.K., Zhu, D., King, C.A., Ashworthy, L.J., Kumar, S. & Hawkins, R.E. (1995) Idiotypic DNA vaccines against B cell lymphoma. Immunology Reviews, 145, 211-229.
36. Townsend, A. & Bodmer, H. (1989) Antigen recognition by class I-restricted T lymphocytes. Annual Review of Immunology, 7, 601-624.
37. Trowsdale, J., Hanson, I., Mockridge, I., Beck, S., Townsend, A. & Kelly, A. (1990) Sequences encoded in the class II region of MHC related to the 'ABC' superfamily of transporters. Nature, 348, 741-744.
38. Yang, S.Y., Morishima, Y., Cillins, N.H., Alton, T., Pollack, M.S., Yunis, E.J. & Dupont, B. (1984) Comparison of one-dimensional IEF patterns for serologically detectable HLA-A and B allotypes. Immunogenetics, 19, 217-231.